Bio-Modeling Systems: The Mechanisms-Based Mecidicine Company
  • 2017: PRESS-RELEASE: Paris-New-York October 4, 2017: BMSystems, with its 14 independently validated successes to date, is selected by the Galien Foundation for the MedStartUp Award 2017 program first step during the US Galien Prize Forum in New-York.
     
  • 2017: ANNOUNCEMENT: Latest news:  Press-release from Hospices Civils de Lyon about phage therapy success with Pherecydes Pharma bacteriophages. Pherecydes-Pharma, is BMSystems’ first therapeutic spin-off.
     
  • 2017: ANNOUNCEMENT: Paris September 7, 2017: The future of Medicine: Bio-Modeling Systems invited to present at the Summer Universities of Fédération Hospitalière de France
     
  • 2017: ANNOUNCEMENT: Belgium August 26-27, 2017: BMSystems selected to meet Wallonia life Sciences Companies and is invited to the Spa-Francorchamps Formula 1 Race. Great place for top meeting!

  • 2017: ANNOUNCEMENT: Paris July 4, 2017. BMSystems was invited to present at the Conference INSEAD Alumni at BCG Paris Office: Everything you always wanted to know about Digital Health revolution “big promises” but were afraid to ask!

  • 2017: ANNOUNCEMENT: Paris January 17, 2017: BMSytems was invited at the France-India healthcare Summit to present its Computer Augmented Deductive Intelligence platform and its operational successes

  • 2017: ANNOUNCEMENT: Paris January 17, 2017: BMSytems invited to present its collaborative success story with CEA life Sciences at the 10 years anniversary of Medicen Paris Region Health cluster

  • 2017: Happy New Year: Our 8 Resolutions for 2017 to be ready for the upcoming bubble explosion! - Bonne Année: Nos 8 Résolutions pour 2017
     
  • 2016: INTERVIEW (Post LinkedIn FR avec explications): "Drug Discovery and health Big Data. The enormous Bubble will explode.” (Post LinkedIn ENG with all the explanations)  Manuel GEA, CEO of BMSystems in Biotech & Finances the leading biotech sector information letter

  • 2016: ANNOUNCEMENT: Paris October 5, 2016: BMSystems' CEO invited to present its digital-biology strategy and achievements at the inaugural session of Medicen Paris Region 10th years anniversary

  • 2016: PRESS RELEASE: Paris September 5, 2016: BMSystems selected to present CADI Discovery at the Connexion R&D conference organized by COSMETIC-VALLEY the leading Perfumery & Cosmetic cluster in France.

  • 2016: ANNOUNCEMENT August 1, 2016: BIO-MODELING SYSTEMS' novel Parkinson's therapy mentioned in a Report Covering 179 Companies. A new recognition of CADI Discovery capability to generate novel therapeutic strategies in complex human diseases of which CNS

  • 2016: Updated: Inaugural Presentation Bio-Entrepreneur 2015: The future will be digital and biology, but who will lead? Google? Watson? Alone or MDs, Physiologists, Biologists educating and mastering them combining diagnostics, therapies, connected devices and IT technologies?
Bio-Modeling Systems: The Mechanisms-Based Mecidicine Companys

CADI™ Discovery - Research Production

14 CADI™ successes programs to date:

For all details download our short Presentation

  1. Mechanisms of pathogenesis & clinical progression of Creutzfeldt-Jakob Disease;
  2. Mechanisms of anti-connexin agents for modulating the therapeutic effect of psychotropic and neurodegenerative drugs;
  3. Cellular & metabolic mechanisms associated with chronic anxiety;
  4. Novel antiglycemic mechanism;
  5. Anti-metastatic mechanisms of the RGD15 peptide;
  6. Mechanisms of Ras-mediated breast cancer oncogenesis;
  7. Mechanisms of breast cancer resistance to tamoxifen;
  8. Regression mechanisms of the Müllerian duct;
  9. Mechanisms of differential melanosome degradation;
  10. Context-dependent functions of OA1 protein;
  11. Context-dependent functions OCA2 protein;
  12. Context-dependent functions SLC45A2 (MATP) protein;
  13. Engineered bacteriophage banks and the control of multi-resistant pathogens;
  14. Bioproduction and hemisynthesis of 18-methyl eicosanoic acid;

 

CADI™ programs to date in 8 domains:

  1. Infection-Immunology domain: Chronic Fatigue Syndrome; Ebola virus ecology; Hepatitis C; Auto-immune global concept
  2. Micorbiotas: Skin, lung, gut, etc, ecology, physiology & metabolic mechanisms
  3. CNS / PNS Inflammation domain: Psychiatric & neurologic treatment; Creutzfeldt-Jakob disease mechanisms; Alzheimer's Disease Mechanisms; Parkinson's Disease Treatment; Psychiatric inflammatory mechanisms; Fibromyalgia, facial pain; Pain (Central/Peripheral); Migraine Mechanisms; Multiple Sclerosis Mechanisms; Psychiatric disorders biomarkers
  4. Metabolism / Inflammation domain: Hypercholestemia Mechanisms; diabetes type 2; New global concept for Diabetes type 1; Metabolic Syndrome.
  5. Cancer / Inflammation domain: Breast cancer-Hras; Tamoxifen resistance; Specific Metastasis control; Global Metastasis control
  6. Tissue Differentiation domain: Müllerian regression Mechanisms; Adipocytes growth control
  7. Dermatology / Inflammation domain: Skin Contact Allergy Mechanisms; Skin pigmentation Mechanisms; Skin pigmentation Modulation; Skin aging Mechanisms; Modulation of skin hydration; Modulation of the lipid constituents of the skin barrier; Novel Hair Loss Mechanisms
  8. Industrial Biotech domain: Program Synthons; industrial biotech; Human Glycosylation with Yeast
     
  • Rare diseases/ Orphan diseases/ Orphan drugs based on CADI Discovery repositioning

IMPORTANT: We are not domain dependent, but smart data access dependant

Bio-Modeling Systems: a leading Integrative Heuristic Systems Biology / Predictive Integrative Biology Mechanisms-Based Medicine company that delivers